Dianthus Therapeutics

Quarterly Financials

Values in thousands 2024-09-30 2024-06-30 2024-03-31 2023-12-31
Revenue
$2,172
$1,863
$874
$457
Gross Profit
2,172
1,752
767
354
EBITDA
-29,784
-22,204
-17,737
-10,460
EBIT
-29,900
-22,315
-17,844
-10,563
Net Income
-25,174
-17,607
-13,748
-10,563
Net Change In Cash
2,172
1,863
874
457
Free Cash Flow
-8,422
-14,545
-14,973
-11,864
Cash
33,671
314,169
329,724
132,324
Basic Shares
34,236
34,227
25,665
4,530

Annual Financials

Values in thousands 2023-12-31 2022-12-31 2021-12-31
Revenue
$2,826
$6,417
$1,476
Gross Profit
2,471
6,270
-544
EBITDA
-48,174
-29,558
-13,086
EBIT
-48,529
-29,705
-15,106
Net Income
-43,555
-28,476
-13,109
Net Change In Cash
2,826
6,417
1,476
Free Cash Flow
-36,971
-29,209
-9,937
Cash
132,325
15,365
7,638
Basic Shares
5,153
3,747
3,434

Earnings Calls

Quarter EPS
2024-09-30
-$0.72
2024-06-30
-$0.51
2024-03-31
-$0.54
2023-12-31
-$0.71